ArticleEye (London, England)2025
The effect of altitude on the incidence of keratoconus in Israel-a population-based study.
Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the correlation between residential altitude and keratoconus incidence in Israel, considering potential ethnic variations.
methodsThis retrospective population-based study analysed data from Israel's largest healthcare provider from 2005 to 2020. Keratoconus patients were identified using ICD-9 codes. Annual keratoconus incidence was calculated for three residential altitude groups: below 0 m, 0-500 m, and above 500 m. To address ethnic confounding, keratoconus prevalence rates in 2019 were analysed across altitude groups for both the total population and the Jewish subgroup, Israel's largest ethnic group.
resultsThe study population increased from 3,440,265 individuals in 2005 to 4,316,825 in 2020. Among 14,769 keratoconus patients (mean age: 35.19 ± 13.3 years), the average incidence was 24.04 per 100,000 individuals. Annual keratoconus incidence increased significantly with altitude 17.01, 23.73, and 26.63 per 100,000 individuals in regions below 0 m, 0-500 m, and above 500 m, respectively (0 < 0.05). In 2019, total prevalence rate was 0.40%, increasing with altitude: 0.37%, 0.43%, and 0.56%. The Jewish population exhibited a similar pattern: 0.35%, 0.39% and 0.56%. Logistic regression analysis revealed significantly higher odds of keratoconus above 500 m compared to lower altitudes in both populations (p < 0.05).
conclusionA positive correlation was identified between altitude and keratoconus incidence and prevalence in both the total population and the Jewish subgroup. These findings indicate altitude may be a significant risk factor for keratoconus, warranting future investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.